HanesDSWeirMR. The beta blockers: are they as protective in hypertension as in other cardiovascular conditions?J Clin Hypertension. 2001;3(4):236–243.
2.
KaragiannisATziomalosKAnagnostisP. The effect of antihypertensive agents on insulin sensitivity, lipids and haemostasis. Curr Vasc Pharmacol. 2010;8(6):792–803.
3.
PoweDGVossMJZänkerKS. Beta-blocker drug therapy reduces secondary cancer formation in breast cancer and improves cancer specific survival. Oncotarget. 2010;1(7):628–638.
4.
SipahiIDebanneSMRowlandDY. Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials. Lancet Oncol. 2010;11(7):627–636.
5.
BangaloreSKumarSKjeldsenSE. Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324,168 participants from randomised trials. Lancet Oncol. 2011;12(1):65–82.
6.
LiCIMaloneKEWeissNS. Relation between use of antihypertensive medications and risk of breast carcinoma among women ages 65-79 years. Cancer. 2003;98(7):1504–1513.
7.
KayeDMKrumH. Drug discovery for heart failure: a new era or the end of the pipeline?Nat Rev Drug Discov. 2007;6(2):127–139.
8.
SmithREAshiyaM. Antihypertensive therapies. Nat Rev Drug Discov. 2007;6(8):597–598.
9.
ZamanMAOparilSCalhounDA. Drugs targeting the renin-angiotensin-aldosterone system. Nat Rev Drug Discov. 2002;1(8):621–636.
10.
GeorgeAJThomasWGHannanRD. The renin-angiotensin system and cancer: old dog, new tricks. Nat Rev Cancer. 2010;10(11):745–759.
11.
ArrietaOGuevaraPEscobarE. Blockage of angiotensin II type I receptor decreases the synthesis of growth factors and induces apoptosis in C6 cultured cells and C6 rat glioma. Br J Cancer. 2005;92(7):1247–1252.
12.
BanerjeeYTaranikantiVAlriyamiM. Can antihypertensive drugs increase the risk of cancer?Trends Mol. Med. 2011;17(4):175–176.
13.
RambergHEideTKrobertKA. Hormonal regulation of β2-adrenergic receptor level in prostate cancer. Prostate. 2008;68(10):1133–1142.
14.
IaccarinoGCiccarelliMSorrientoD. Ischemic neoangiogenesis enhanced by beta2-adrenergic receptor overexpression: a novel role for the endothelial adrenergic system. Circ Res. 2005;97(11):1182–1189.
15.
SloanEKPricemanSJCoxBF. The sympathetic nervous system induces a metastatic switch in primary breast cancer. Cancer Res. 2010;70(18):7042–7052.
16.
BradleyD. Why big pharma needs to learn the three ‘R’s. Nat Rev Drug Discov. 2005;4(6):446.
